Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Translocated intimin receptor (Tir) is a pivotal virulence protein utilized by attaching and effacing (A/E) pathogens, most notably Enteropathogenic Escherichia coli (EPEC) and Enterohemorrhagic Escherichia coli (EHEC) (UniProt: P09151). Unlike traditional host receptors, Tir is produced by the bacterium and injected directly into the host intestinal epithelial cell membrane via a type III secretion system (T3SS) (PMID: 9353126). Once integrated into the host membrane, Tir serves as the specific receptor for the bacterial outer membrane protein, intimin (PMID: 11346795). This Tir-intimin interaction triggers a cascade of host signaling events, including the recruitment of actin-modulating proteins that lead to the formation of actin-rich pedestals beneath the adherent bacteria (PMID: 15123611). These pedestals are essential for stable colonization and the effacement of microvilli, leading to severe diarrheal symptoms and, in the case of EHEC, potential systemic complications like hemolytic uremic syndrome (PMID: 25605758). Given its essential role in pathogenesis and its absence in human biology, Tir represents a highly specific target for anti-infective strategies, including vaccines and small-molecule inhibitors designed to disrupt bacterial adhesion (PMID: 21930754).
Blockade of the interaction between the bacterial intimin protein and the host-integrated Tir receptor to prevent stable attachment and pedestal formation (PMID: 11346795).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Translocated intimin receptor (Tir) (Tir).